Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Contract Research
Return to: PBR Home | Contract Research & Services | Contract Research | News
Search Refinements

Contract Research News

View news from other Pharmaceutical sectors:
31-45 of 2107 results
Sanofi, Verily Life Sciences create new JV to develop diabetes management platform
By PBR Staff Writer
French pharmaceutical firm Sanofi and Alphabet subsidiary Verily Life Sciences have launched a new joint venture (JV) called Onduo, to develop comprehensive diabetes management platform.
Contract Research & Services > Contract Research > News
Biothera collaborates with Merck for combination cancer immunotherapy trials in multiple indications
Biothera Pharmaceuticals announced a collaboration with Merck to expand the companies’ ongoing clinical program evaluating KEYTRUDA (pembrolizumab), Merck’s anti-PD-1 inhibitor, in combination with Biothera’s Imprime PGG, a Pathogen Associated Molecular Patterning molecule, or PAMP.
Contract Research & Services > Contract Research > News
Xycrobe signs research deal with Johnson & Johnson Consumer
Xycrobe Therapeutics has entered into a research agreement with Johnson & Johnson Consumer.
Contract Research & Services > Contract Research > News
Abeona, EBRP and EB MRF to collaborate on epidermolysis bullosa treatments
Abeona Therapeutics, EB Research Partnership (EBRP) and EB Research Medical Foundation (EBMRF) announced a collaboration focusing on gene therapy treatments for epidermolysis bullosa (EB), a group of devastating rare genetic skin disorders impacting children; characterized by skin blisters and erosions all over the body.
Contract Research & Services > Contract Research > News
Proteostasis completes preclinical milestone in collaboration with Astellas Pharma
Proteostasis Therapeutics has completed a key preclinical milestone in its collaboration with Astellas Pharma.
Contract Research & Services > Contract Research > News
Codexis completes obligations under research and development deal with biopharmaceutical firm
Codexis has completed its obligations under a collaborative research and development agreement with a leading global biopharmaceutical company.
Contract Research & Services > Contract Research > News
Pfizer, Western Oncolytics establish immuno-oncology research collaboration
Pfizer and Western Oncolytics have entered into a development collaboration, license and option agreement to advance Western Oncolytics’ novel oncolytic vaccinia virus, WO-12.
Contract Research & Services > Contract Research > News
Bristol-Myers Squibb, Janssen collaborate on lung cancer treatment
By PBR Staff Writer
Bristol-Myers Squibb (BMS) and Janssen Biotech have signed a clinical study collaboration agreement to evaluate the combination of two immuno-oncology compounds in patients with non-small cell lung cancer (NSCLC).
Contract Research & Services > Contract Research > News
AbbVie, Bristol-Myers Squibb partner on combo treatment for lung cancer
By PBR Staff Writer
AbbVie and Bristol-Myers Squibb (BMS) are collaborating on a clinical trial combining both companies’ checkpoint inhibitors to treat relapsed extensive-stage small cell lung cancer (SCLC).
Contract Research & Services > Contract Research > News
Tiziana acquires bio-repository from Shardna
By PBR Staff Writer
UK-based clinical stage biotechnology company Tiziana Life Sciences has acquired the genetic data of about 13,000 people from the Ogliastra region of Sardinia.
Contract Research & Services > Contract Research > News
Juno Therapeutics acquires Boston-based RedoxTherapies
By PBR Staff Writer
Biopharmaceutical firm Juno Therapeutics has acquired privately held Boston-based RedoxTherapies.
Contract Research & Services > Contract Research > News
Eli Lilly, Boehringer Ingelheim form clinical trial partnership in metastatic breast cancer
By PBR Staff Writer
Pharmaceutical giants Eli Lilly and Company and Boehringer Ingelheim have announced a new partnership focused on metastatic breast cancer (mBC).
Contract Research & Services > Contract Research > News
Grant funding secured to explore Midatech's gold nanoparticle technology in immunotherapy
Midatech Pharma announced that its research collaboration with Cardiff University in autoimmune therapies has received a two-year funding grant from JDRF (Juvenile Diabetes Research Foundation), for a project entitled "Gold nanoparticles coupled with selective PAMP ligands to deliver antigen specific immunotherapy" in diabetes, the commonest autoimmune disease worldwide.
Contract Research & Services > Contract Research > News
BMS, PsiOxus Therapeutics to study immuno-oncology combination
By PBR Staff Writer
Bristol-Myers Squibb (BMS) and UK-based PsiOxus Therapeutics have agreed to work together on a new combination therapy targeting various tumor types in late-stage cancer patients.
Contract Research & Services > Contract Research > News
TB Alliance, Takeda partner to investigate novel compounds for tuberculosis treatment
The Global Alliance for TB Drug Development (TB Alliance) and Takeda Pharmaceutical Company have entered into an agreement that further explores hits generated from a high-throughput screening program conducted to find novel compounds to improve treatment of tuberculosis (TB).
Contract Research & Services > Contract Research > News
31-45 of 2107 results